Autologous mesoangioblasts clinical trials

Assess efficacy of intra-arterial autologous myogenic stam cell therapy for m.3243A>G mutation carriers

This study is testing a new type of cell therapy for people with a genetic muscle condition called m.3243A>G mitochondrial myopathy. It aims to see if the therapy is safe and if it can improve muscle strength and reduce tiredness in people's arms.